Literature DB >> 9810896

Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin.

T Dirschka1, U Kastner, S Behrens, P Altmeyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9810896     DOI： 10.1016/s0190-9622(98)70052-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Clinical uses of intravenous immunoglobulin.

Authors:  S Jolles; W A C Sewell; S A Misbah
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 2.  Pyoderma gangrenosum treated with high-dose intravenous immunoglobulins: Two cases and review of the literature.

Authors:  Nicolas Meyer; Valérie Ferraro; Marie-Henriette Mignard; Henri Adamski; Jacqueline Chevrant-Breton
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

3.  Large leg ulcers due to autoimmune diseases.

Authors:  Alexander P Rozin; Dana Egozi; Yehuda Ramon; Kohava Toledano; Yolanda Braun-Moscovici; Doron Markovits; Daniel Schapira; Reuven Bergman; Yehuda Melamed; Yehuda Ullman; Alexandra Balbir-Gurman
Journal:  Med Sci Monit       Date:  2011-01

4.  Intravenous immunoglobulin as salvage therapy in refractory pyoderma gangrenosum: report of a case and review of the literature.

Authors:  John Cafardi; Naveed Sami
Journal:  Case Rep Dermatol       Date:  2014-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.